GelMA microneedle-loaded bio-derived nanovaccine shows therapeutic potential for gliomas

Glioma is the most common primary malignant tumor of the central nervous system in adults. Although immunotherapy, especially tumor vaccines, has made some progress in the treatment of gliomas compared with surgery and radiotherapy. However, the lack of specific or relevant tumor antigens severely l...

Full description

Bibliographic Details

Published in:	Science and Technology of Advanced Materials
Main Authors:	Deguang Qin, Wenyong Huang, Dengke Shen, Longyi Chong, Zeyu Yang, Boyang Wei, Xifeng Li, Ran Li, Wenchao Liu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Subjects:	Bio-derived nanovaccine GelMA gel microneedle vaccine glioma cellular immunity
Online Access:	https://www.tandfonline.com/doi/10.1080/14686996.2024.2426444